
Gilead Sciences Inc
NASDAQ:GILD

Intrinsic Value
The intrinsic value of one
GILD
stock under the Base Case scenario is
101.51
USD.
Compared to the current market price of 112.39 USD,
Gilead Sciences Inc
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Gilead Sciences Inc
Fundamental Analysis

Gilead’s heavy reliance on its HIV portfolio could hinder long-term growth if new competitive therapies and emerging generics erode market share faster than forecast, putting pressure on revenues and margins.
Gilead’s robust HIV franchise, led by Biktarvy, continues to post solid growth and enjoy strong patent protection, providing a stable revenue base and healthy cash flow to fund R&D and strategic acquisitions.

Revenue & Expenses Breakdown
Gilead Sciences Inc
Balance Sheet Decomposition
Gilead Sciences Inc
Current Assets | 19.2B |
Cash & Short-Term Investments | 10B |
Receivables | 4.4B |
Other Current Assets | 4.8B |
Non-Current Assets | 39.8B |
PP&E | 5.4B |
Intangibles | 28.3B |
Other Non-Current Assets | 6.1B |
Free Cash Flow Analysis
Gilead Sciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Gilead Sciences Inc
Revenue
|
28.8B
USD
|
Cost of Revenue
|
-6.3B
USD
|
Gross Profit
|
22.5B
USD
|
Operating Expenses
|
-11.7B
USD
|
Operating Income
|
10.8B
USD
|
Other Expenses
|
-10.3B
USD
|
Net Income
|
480m
USD
|
GILD Profitability Score
Profitability Due Diligence
Gilead Sciences Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Score
Gilead Sciences Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
GILD Solvency Score
Solvency Due Diligence
Gilead Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Score
Gilead Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for
GILD
is 112.8 USD
with a low forecast of 82.82 USD and a high forecast of 147 USD.
Dividends
Current shareholder yield for GILD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GILD
stock under the Base Case scenario is
101.51
USD.
Compared to the current market price of 112.39 USD,
Gilead Sciences Inc
is
Overvalued by 10%.